A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration

Nature Methods

Volumn 2, Issue 6, 2005, Pages 419-426

  Buch, Thorsten ^a   Heppner, Frank L ^b   Tertilt, Christine ^a   Heinen, Tobias J A J ^a   Kremer, Marcel ^c   Wunderlich, F Thomas ^a   Jung, Steffen ^d   Waisman, Ari ^a,e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CRE RECOMBINASE; DIPHTHERIA TOXIN; DIPHTHERIA TOXIN RECEPTOR; NEUTRALIZING ANTIBODY; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CELL ABLATION; CELL DISRUPTION; CELL FUNCTION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; MOUSE STRAIN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL SURVIVAL; DIPHTHERIA TOXIN; INTEGRASES; MICE; MICE, TRANSGENIC; OLIGODENDROGLIA; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

ANIMALIA; MUS MUSCULUS;

EID: 21444454735     PISSN: 15487091     EISSN: None     Source Type: Journal    
DOI: 10.1038/nmeth762     Document Type: Article

References (49)

1. Huang, S. & Moody, S.A. Does lineage determine the dopamine phenotype in the tadpole hypothalamus?: A quantitative analysis. J. Neurosci. 12, 1351-1362 (1992).
2. Serbedzija, G.N., Chen, J.N. & Fishman, M.C. Regulation in the heart field of zebrafish. Development 125, 1095-1101 (1998).
3. Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A B cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350, 423-426 (1991).
4. Palmiter, R.D. et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50, 435-443 (1987).
5. Breitman, M.L. et al. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science 238, 1563-1565 (1987).
6. Woodruff, M.F. & Anderson, N.A. Effect of lymphocyte depletion by thoracic duct fistula and administration of anti-lymphocytic serum on the survival of skin homografts in rats. Nature 200, 702 (1963).
7. Franklin, R.J., Crang, A.J. & Blakemore, W.F. The role of astrocytes in the remyelination of glia-free areas of demyelination. Adv. Neurol. 59, 125-133 (1993).
8. Borrelli, E., Heyman, R., Hsi, M. & Evans, R.M. Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA 85, 7572-7576 (1988).
9. Clark, A.J. et al. Selective cell ablation in transgenic mice expression E. coli nitroreductase. Gene Ther. 4, 101-110 (1997).
10. Palmiter, R. Interrogation by toxin. Nat. Biotechnol. 19, 731-732 (2001).
11. al-Shawi, R. et al. The herpes simplex virus type 1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter. Mol. Cell. Biol. 11, 4207-4216 (1991).
12. Naglich, J.G., Metherall, J.E., Russell, D.W. & Eidels, L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69, 1051-1061 (1992).
13. Middlebrook, J.L. & Dorland, R.B. Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity. Can. J. Microbiol. 23, 183-189 (1977).
14. Pappenheimer, A.M., Jr., Harper, A.A., Moynihan, M. & Brockes, J.P. Diphtheria toxin and related proteins: effect of route of injection on toxicity and the determination of cytotoxicity for various cultured cells. J. Infect. Dis. 145, 94-102 (1982).
15. Saito, M. et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19, 746-750 (2001).
16. Jung, S. et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002).
17. Cha, J.H., Chang, M.Y., Richardson, J.A. & Eidels, L. Transgenic mice expressing the diphtheria toxin receptor are sensitive to the toxin. Mol. Microbiol. 49, 235-240 (2003).
18. Drazin, R., Kandel, J. & Collier, R.J. Structure and activity of diphtheria toxin. II. Attack by trypsin at a specific site within the intact toxin molecule. J. Biol. Chem. 246, 1504-1510 (1971).
19. Gill, D.M. & Dinius, L.L. Observations on the structure of diphtheria toxin. J. Biol. Chem. 246, 1485-1491 (1971).
20. Honjo, T., Nishizuka, Y., Kato, I. & Hayaishi, O. Adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis by diphtheria toxin. J. Biol. Chem. 246, 4251-4260 (1971).
21. Yamaizumi, M., Mekada, E., Uchida, T. & Okada, Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 15, 245-250 (1978).
22. Kühn, R. & Schwenk, F. Advances in gene targeting methods. Curr. Opin. Immunol. 9, 183-188 (1997).
23. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. & Rajewsky, K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106 (1994).
24. Lakso, M. et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89, 6232-6236 (1992).
25. Zambrowicz, B.P. et al. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. USA 94, 3789-3794 (1997).
26. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
27. Mao, X., Fujiwara, Y. & Orkin, S.H. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. USA 96, 5037-5042 (1999).
28. Capecchi, M.R. Altering the genome by homologous recombination. Science 244, 1288-1292 (1989).
29. Kontgen, F., Suss, G., Stewart, C., Steinmetz, M. & Bluethmann, H. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5, 957-964 (1993).
30. Peitz, M., Pfannkuche, K., Rajewsky, K. & Edenhofer, F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. USA 99, 4489-4494 (2002).
31. Lee, P.P. et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15, 763-774 (2001).
32. Sawada, S., Scarborough, J.D., Killeen, N. & Littman, D.R. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell 77, 917-929 (1994).
33. Koopman, G. et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1420 (1994).
34. Rickert, R.C., Roes, J. & Rajewsky, K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25, 1317-1318 (1997).
35. Pasparakis, M., Schmidt-Supprian, M. & Rajewsky, K. IκB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196, 743-752 (2002).
36. Ballabh, P., Braun, A. & Nedergaard, M. The blood-brain barrier: an overview: Structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13 (2004).
37. Wrobel, C.J., Wright, D.C., Dedrick, R.L. & Youle, R.J. Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy. J. Neurosurg. 72, 946-950 (1990).
38. Pham-Dinh, D. et al. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90, 7990-7994 (1993).
39. Reynolds, R. & Wilkin, G.P. Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development 102, 409-425 (1988).
40. Coetzee, T., Suzuki, K., Nave, K.A. & Popko, B. Myelination in the absence of galactolipids and proteolipid proteins. Mol. Cell. Neurosci. 14, 41-51 (1999).
41. Mathis, C., Collin, L. & Borrelli, E. Oligodendrocyte ablation impairs cerebellum development. Development 130, 4709-4718 (2003).
42. Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081 (1995).
43. Cobbold, S.P., Martin, G., Qin, S. & Waldmann, H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323, 164-166 (1986).
44. + T cell regulation during the induction phase of the response. Eur. J. Immunol. 25, 2643-2649 (1995).
45. Greenwood, J., Clark, M. & Waldmann, H. Structural motifs involved in human IgG antibody effector functions. Eur. J. Immunol. 23, 1098-1104 (1993).
46. Rep, M.H. et al. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-γ-secreting TH1 cells in humans. J. Clin. Invest. 99, 2225-2231 (1997).
47. Vooijs, M., Jonkers, J. & Berns, A. A highly efficient ligand-regulated Cre recombinase mouse line shows that loxP recombination is position dependent. EMBO Rep. 2, 292-297 (2001).
48. Torres, R.M. & Kühn, R. Laboratory protocols for conditional gene targeting. (Oxford University Press, Oxford, 1997).
49. + B cells upon transfer of peritoneal cells into allotype-congenic newborn mice. Eur. J. Immunol. 17, 521-528 (1987).